Aslan Pharmaceuticals Ltd (NASDAQ:ASLN)
| 3.92 Delayed Data As of May 26 |  -0.03 / -0.76%Today’s Change | 1.70 Today|||52-Week Range 4.94 | +117.78% Year-to-Date |
Latest ASLN News | Press Releases
No recent news for Aslan Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 3.94 |
| Today’s open | 4.00 |
| Day’s range | 3.80 - 4.00 |
| Volume | 8,420 |
| Average volume (3 months) | 44,156 |
| Market cap | $63.8M |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -53.21% |
| Earnings growth (this year) | -41.58% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.50 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DYAIDyadic International... | +0.13 | +6.31% |
| PIRSPieris Pharmaceutica... | -0.07 | -8.54% |
| CSBRChampions Oncology I... | -0.08 | -1.57% |
| FIXXHomology Medicines I... | +0.01 | +0.99% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | August 11, 2023 |
| EPS forecast (this quarter) | -$0.85 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$51.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
